skip to main content

brainstorm askiatroX medicines

simulations beta

loading page…

learn & practise

exams international doctors free questions Socratic Tutor rounds stat clinical connections academy journal tool guides

clinical reference

askiatroX knowledge centre medicines UK / NICE guidance international guidance calculators q&a library

trust & support

how it works methodology account & support frequently asked questions about us clinical safety consultancy

legal

mobile app · scan to download

Medicines ErdafitinibQuestion & answer

Erdafitinib · Medicine question

Which nail disorders can occur with erdafitinib treatment?

iatroX medicinesPublished 8 November 2026

The answer

Answer

Nail disorders including onycholysis, nail discolouration and paronychia can occur very commonly during Balversa (erdafitinib) treatment.

Sources for this answer

Balversa 3mg film-coated tabletsJanssen-Cilag Ltd (a Johnson & Johnson Company) · emc · SmPC §4.4 Special warnings and precautions for use · Version 3Document updated 3 June 2026

Sources checked 8 November 2026

Explore this learning need in CPDTake this topic to CPD, then choose your learning context and available question library.

The full medicine guide

More questions about Erdafitinib

Why are sun-protective clothing or sunscreen recommended during erdafitinib treatment?How can erdafitinib affect the efficacy of hormonal contraceptives?How much sodium does each Balversa (erdafitinib) 3 mg film-coated tablet contain?What fetal risks are associated with erdafitinib during pregnancy?Have the safety and efficacy of erdafitinib been established in patients under 18 years of age?How does fluconazole affect erdafitinib exposure?

Erdafitinib

Read the wider context, including uses, precautions and the sources behind this medicine guide.

Read the Erdafitinib guide

More clinical questions?

Explore the tools and reference material available on iatroX.

Explore askiatroX